
    
      Women defined as having iron deficiency anemia based on a low hemoglobin as defined by the
      American College of Obstetrics and Gynecology and a low serum ferritin, in the absence of
      hemoglobinopathy, will be randomized to ferrous sulfate 325mg PO daily or PO twice daily.
    
  